The global market for Tranexamic Acid API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tranexamic Acid API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tranexamic Acid API.
The Tranexamic Acid API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tranexamic Acid API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tranexamic Acid API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hunan Huateng Pharmaceutical
Xian Libang Pharmaceutical
Hangzhou Longshine Bio-Tech
Inabata France S.A.S
Transo-Pharm Handels GmbH
Malladi Drugs & Pharmaceuticals
Rochem International
Metrochem API
Ami Lifesciences
Supriya Lifescience
ALP Pharm
Kyowa Pharma Chemical
Pfizer Inc
Shilpa Medicare
Solara Active Pharma Sciences
Vitalpharms
by Type
0.98
0.99
Others
by Application
Tablets
Capsules
Injection
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tranexamic Acid API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tranexamic Acid API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tranexamic Acid API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Tranexamic Acid API Market Overview
1.1 Product Definition
1.2 Tranexamic Acid API by Type
1.2.1 Global Tranexamic Acid API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Tranexamic Acid API by Application
1.3.1 Global Tranexamic Acid API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Injection
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tranexamic Acid API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Tranexamic Acid API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Tranexamic Acid API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Tranexamic Acid API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tranexamic Acid API Production Market Share by Manufacturers (2020-2025)
2.2 Global Tranexamic Acid API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Tranexamic Acid API, Industry Ranking, 2023 VS 2024
2.4 Global Tranexamic Acid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Tranexamic Acid API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Tranexamic Acid API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tranexamic Acid API, Product Offered and Application
2.8 Global Key Manufacturers of Tranexamic Acid API, Date of Enter into This Industry
2.9 Tranexamic Acid API Market Competitive Situation and Trends
2.9.1 Tranexamic Acid API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tranexamic Acid API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tranexamic Acid API Production by Region
3.1 Global Tranexamic Acid API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Tranexamic Acid API Production Value by Region (2020-2031)
3.2.1 Global Tranexamic Acid API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Tranexamic Acid API by Region (2026-2031)
3.3 Global Tranexamic Acid API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Tranexamic Acid API Production Volume by Region (2020-2031)
3.4.1 Global Tranexamic Acid API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Tranexamic Acid API by Region (2026-2031)
3.5 Global Tranexamic Acid API Market Price Analysis by Region (2020-2025)
3.6 Global Tranexamic Acid API Production and Value, Year-over-Year Growth
3.6.1 North America Tranexamic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Tranexamic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Tranexamic Acid API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Tranexamic Acid API Production Value Estimates and Forecasts (2020-2031)
4 Tranexamic Acid API Consumption by Region
4.1 Global Tranexamic Acid API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Tranexamic Acid API Consumption by Region (2020-2031)
4.2.1 Global Tranexamic Acid API Consumption by Region (2020-2025)
4.2.2 Global Tranexamic Acid API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Tranexamic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Tranexamic Acid API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tranexamic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Tranexamic Acid API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tranexamic Acid API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Tranexamic Acid API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tranexamic Acid API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Tranexamic Acid API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Tranexamic Acid API Production by Type (2020-2031)
5.1.1 Global Tranexamic Acid API Production by Type (2020-2025)
5.1.2 Global Tranexamic Acid API Production by Type (2026-2031)
5.1.3 Global Tranexamic Acid API Production Market Share by Type (2020-2031)
5.2 Global Tranexamic Acid API Production Value by Type (2020-2031)
5.2.1 Global Tranexamic Acid API Production Value by Type (2020-2025)
5.2.2 Global Tranexamic Acid API Production Value by Type (2026-2031)
5.2.3 Global Tranexamic Acid API Production Value Market Share by Type (2020-2031)
5.3 Global Tranexamic Acid API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Tranexamic Acid API Production by Application (2020-2031)
6.1.1 Global Tranexamic Acid API Production by Application (2020-2025)
6.1.2 Global Tranexamic Acid API Production by Application (2026-2031)
6.1.3 Global Tranexamic Acid API Production Market Share by Application (2020-2031)
6.2 Global Tranexamic Acid API Production Value by Application (2020-2031)
6.2.1 Global Tranexamic Acid API Production Value by Application (2020-2025)
6.2.2 Global Tranexamic Acid API Production Value by Application (2026-2031)
6.2.3 Global Tranexamic Acid API Production Value Market Share by Application (2020-2031)
6.3 Global Tranexamic Acid API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hunan Huateng Pharmaceutical
7.1.1 Hunan Huateng Pharmaceutical Tranexamic Acid API Company Information
7.1.2 Hunan Huateng Pharmaceutical Tranexamic Acid API Product Portfolio
7.1.3 Hunan Huateng Pharmaceutical Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hunan Huateng Pharmaceutical Main Business and Markets Served
7.1.5 Hunan Huateng Pharmaceutical Recent Developments/Updates
7.2 Xian Libang Pharmaceutical
7.2.1 Xian Libang Pharmaceutical Tranexamic Acid API Company Information
7.2.2 Xian Libang Pharmaceutical Tranexamic Acid API Product Portfolio
7.2.3 Xian Libang Pharmaceutical Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Xian Libang Pharmaceutical Main Business and Markets Served
7.2.5 Xian Libang Pharmaceutical Recent Developments/Updates
7.3 Hangzhou Longshine Bio-Tech
7.3.1 Hangzhou Longshine Bio-Tech Tranexamic Acid API Company Information
7.3.2 Hangzhou Longshine Bio-Tech Tranexamic Acid API Product Portfolio
7.3.3 Hangzhou Longshine Bio-Tech Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.3.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.4 Inabata France S.A.S
7.4.1 Inabata France S.A.S Tranexamic Acid API Company Information
7.4.2 Inabata France S.A.S Tranexamic Acid API Product Portfolio
7.4.3 Inabata France S.A.S Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Inabata France S.A.S Main Business and Markets Served
7.4.5 Inabata France S.A.S Recent Developments/Updates
7.5 Transo-Pharm Handels GmbH
7.5.1 Transo-Pharm Handels GmbH Tranexamic Acid API Company Information
7.5.2 Transo-Pharm Handels GmbH Tranexamic Acid API Product Portfolio
7.5.3 Transo-Pharm Handels GmbH Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Transo-Pharm Handels GmbH Main Business and Markets Served
7.5.5 Transo-Pharm Handels GmbH Recent Developments/Updates
7.6 Malladi Drugs & Pharmaceuticals
7.6.1 Malladi Drugs & Pharmaceuticals Tranexamic Acid API Company Information
7.6.2 Malladi Drugs & Pharmaceuticals Tranexamic Acid API Product Portfolio
7.6.3 Malladi Drugs & Pharmaceuticals Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Malladi Drugs & Pharmaceuticals Main Business and Markets Served
7.6.5 Malladi Drugs & Pharmaceuticals Recent Developments/Updates
7.7 Rochem International
7.7.1 Rochem International Tranexamic Acid API Company Information
7.7.2 Rochem International Tranexamic Acid API Product Portfolio
7.7.3 Rochem International Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Rochem International Main Business and Markets Served
7.7.5 Rochem International Recent Developments/Updates
7.8 Metrochem API
7.8.1 Metrochem API Tranexamic Acid API Company Information
7.8.2 Metrochem API Tranexamic Acid API Product Portfolio
7.8.3 Metrochem API Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Metrochem API Main Business and Markets Served
7.8.5 Metrochem API Recent Developments/Updates
7.9 Ami Lifesciences
7.9.1 Ami Lifesciences Tranexamic Acid API Company Information
7.9.2 Ami Lifesciences Tranexamic Acid API Product Portfolio
7.9.3 Ami Lifesciences Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Ami Lifesciences Main Business and Markets Served
7.9.5 Ami Lifesciences Recent Developments/Updates
7.10 Supriya Lifescience
7.10.1 Supriya Lifescience Tranexamic Acid API Company Information
7.10.2 Supriya Lifescience Tranexamic Acid API Product Portfolio
7.10.3 Supriya Lifescience Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Supriya Lifescience Main Business and Markets Served
7.10.5 Supriya Lifescience Recent Developments/Updates
7.11 ALP Pharm
7.11.1 ALP Pharm Tranexamic Acid API Company Information
7.11.2 ALP Pharm Tranexamic Acid API Product Portfolio
7.11.3 ALP Pharm Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 ALP Pharm Main Business and Markets Served
7.11.5 ALP Pharm Recent Developments/Updates
7.12 Kyowa Pharma Chemical
7.12.1 Kyowa Pharma Chemical Tranexamic Acid API Company Information
7.12.2 Kyowa Pharma Chemical Tranexamic Acid API Product Portfolio
7.12.3 Kyowa Pharma Chemical Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Kyowa Pharma Chemical Main Business and Markets Served
7.12.5 Kyowa Pharma Chemical Recent Developments/Updates
7.13 Pfizer Inc
7.13.1 Pfizer Inc Tranexamic Acid API Company Information
7.13.2 Pfizer Inc Tranexamic Acid API Product Portfolio
7.13.3 Pfizer Inc Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Pfizer Inc Main Business and Markets Served
7.13.5 Pfizer Inc Recent Developments/Updates
7.14 Shilpa Medicare
7.14.1 Shilpa Medicare Tranexamic Acid API Company Information
7.14.2 Shilpa Medicare Tranexamic Acid API Product Portfolio
7.14.3 Shilpa Medicare Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Shilpa Medicare Main Business and Markets Served
7.14.5 Shilpa Medicare Recent Developments/Updates
7.15 Solara Active Pharma Sciences
7.15.1 Solara Active Pharma Sciences Tranexamic Acid API Company Information
7.15.2 Solara Active Pharma Sciences Tranexamic Acid API Product Portfolio
7.15.3 Solara Active Pharma Sciences Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Solara Active Pharma Sciences Main Business and Markets Served
7.15.5 Solara Active Pharma Sciences Recent Developments/Updates
7.16 Vitalpharms
7.16.1 Vitalpharms Tranexamic Acid API Company Information
7.16.2 Vitalpharms Tranexamic Acid API Product Portfolio
7.16.3 Vitalpharms Tranexamic Acid API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Vitalpharms Main Business and Markets Served
7.16.5 Vitalpharms Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tranexamic Acid API Industry Chain Analysis
8.2 Tranexamic Acid API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tranexamic Acid API Production Mode & Process Analysis
8.4 Tranexamic Acid API Sales and Marketing
8.4.1 Tranexamic Acid API Sales Channels
8.4.2 Tranexamic Acid API Distributors
8.5 Tranexamic Acid API Customer Analysis
9 Tranexamic Acid API Market Dynamics
9.1 Tranexamic Acid API Industry Trends
9.2 Tranexamic Acid API Market Drivers
9.3 Tranexamic Acid API Market Challenges
9.4 Tranexamic Acid API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hunan Huateng Pharmaceutical
Xian Libang Pharmaceutical
Hangzhou Longshine Bio-Tech
Inabata France S.A.S
Transo-Pharm Handels GmbH
Malladi Drugs & Pharmaceuticals
Rochem International
Metrochem API
Ami Lifesciences
Supriya Lifescience
ALP Pharm
Kyowa Pharma Chemical
Pfizer Inc
Shilpa Medicare
Solara Active Pharma Sciences
Vitalpharms
听
听
*If Applicable.
